Post My Press Release

Free Press Release Distribution

Author: pragya@transparencymarketresearch.com (Page 1 of 23)

Medical Holography Market to Expand at a Modest CAGR of 34% by 2026

The global medical holography market was valued at around US$ 240.0 Mn in 2017 and is anticipated to reach around US$ 3500.0 Mn by 2026, expanding at a CAGR of more than 30.0% from 2018 to 2026. Rise in prevalence of chronic diseases, such as cancer and cardiovascular events, increase in the geriatric population, and intensive research activities being performed to determine the various applications of holographic techniques in different surgical procedures are key factors that are estimated to propel the market during the forecast period.

Obtain Report Details @

https://www.transparencymarketresearch.com/medical-holography-market.html

Holographic technology is widely utilized for virtual display of images of the internal organs, heart, gastric organs, such as pancreas, liver, and the developing embryo for diagnosis of cancer and other chronic disease conditions. Applications of medical holography, such as medical imaging of different parts of body organs suspected of disease, possess potential for the medical holography market in the near future. Thus, further research in the field of medical holography for further utilization offers significant opportunities to the market in the near future.

The global medical holography market was valued around US$ 240 Mn in 2017. It is anticipated to expand at a stable CAGR of more than 34% between 2018 and 2026, according to a new report published by Transparency Market Research (TMR) titled “Medical holography market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. Expansion of the global medical holography market is expected to be driven by technological advancements and increasing usage of 3D medical imaging technology during the forecast period. The medical holography market in North America is expanding at a significant CAGR of above 30.0%, due to high prevalence of chronic diseases, advancements in the health care sector, and increased focus on research and developmental activities. 

Request for Sample Copy of Report @

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=19295

Cancer was the second-leading cause of death, and in 2015, it was responsible for 8.8 million deaths worldwide. Helicobacter pylori infection is the best known carcinogen for gastric cancer. Most gastric cancer cases in Western countries are diagnosed at late stages, when the treatment remains less effective. Increasing prevalence of chronic diseases, such as cancer and cardiovascular diseases, has fueled the demand for diagnostic methods to detect cancer and cardiac diseases at an early stage. The progress of cancer depends upon its stage, and most advanced developments in diagnostics and medical holography technology and devices have therefore focused on early detection. These factors are expected to boost the medical holography market in the near future in order to identify chronic diseases such as cancers and cardiac disorders at an early stage.

Request Report Brochure @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19295

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

Sterilization Equipment and Disinfectant Market is Projected to Increment at a Healthy CAGR 4.5% Between 2018 and 2026

Globalization leads to the outbreak of several diseases, and some of them are lead to surgery. According to the annual plastic surgery procedural statistics, there were almost 15.9 million surgical and minimally-invasive cosmetic procedures performed in the U.S, in 2015, a 2% increase over 2014. This increasing number of surgeries is creating a demand for more sterilization of equipment in order to prevent any microbial infection. A large number of global manufacturers are putting constant efforts to develop and manufacture novel equipment so that the customer can carry out the sterilization process more effectively and smoothly. Demand for low temperature sterilization for moist and heat-sensitive equipment is rising. Key players are focusing on the development of new sterilization equipment and disinfectants with better efficacy. For instance, Becton, Dickinson and Company launched the Genesis, a low temperature rigid sterilization container system, which provides long-lasting protection and sterility maintenance for surgical instrumentation. These key developments are likely to augment the global sterilization equipment and disinfectant market in the near future. However, high price of sterilization equipment and increasing demand for disposable devices are likely to restrain the global sterilization equipment and disinfectant market during the forecast period.

Obtain Report Details @

https://www.transparencymarketresearch.com/sterilization-equipment-market.html

The global sterilization equipment and disinfectant market has been segmented based on method, disinfectant type, end-user and region. In terms of method, the heat sterilization segment is projected to dominate the market. However, the segment is expected to lose market share during the forecast period, due to fewer opportunities for new entrants in the segment. Moreover, the heat sterilization method is not suitable for heat and moist sensitive equipment, the sterilization process damages the equipment.

Request for Sample Copy of Report @

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=389

Transparency Market Research (TMR) has published a new report titled ‘Sterilization Equipment and Disinfectant Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the new report, the global sterilization equipment and disinfectant market was valued above US$ 4,400 Mn in 2017. It is projected to expand at a CAGR of 4.5% from 2018 to 2026.

Rise in geriatric population leads to increase in the number of surgeries that are caused due to severe diseases and performed at hospitals and clinics and increase in number of hospital acquired infection are likely to boost the sterilization equipment and disinfectant market during the forecast period.

Request Report Brochure @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=389

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

Radiopharmaceutical Market is Projected to Increment at a Healthy CAGR 5.4%Between 2017 and 2024

The radiopharmaceutical market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to the segments based on radioisotopes, source, end-user, and geography. A detailed qualitative analysis of drivers and restraints, and opportunities has been provided in the market overview section. Additionally, the section comprises Porters Five Forces Analysis to help understand the competitive landscape in the market. This section also provides market attractiveness analysis in terms of geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global radiopharmaceutical market.

Obtain Report Details @

https://www.transparencymarketresearch.com/radiopharmaceuticals-market.html

The healthcare industry and medical professionals have played a huge role in enhancing the growth prospects of the market vendors. The distributors of radioactive drugs have also helped market players in reaching to wider audiences and expanding their consumer base. On account of the lucrative opportunities that float in the global radiopharmaceuticals market, several new names have made their way into the market. The new market vendors are expected to capitalise on tying up with distributors in order to stand better chances of growth.

Request for Sample Copy of Report @

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=213

The global market for radiopharmaceuticals is expected to grow at a CAGR of 5.4% over the period between 2017 and 2024, finds Transparency Market Research (TMR). The global market for radiopharmaceuticals is prognosticated to accumulate revenues worth US$7,430.8 million by 2024, rising up from a value of US$5,145.1 million in 2017. On the basis of end user, hospitals have emerged as the largest consumer of radiopharmaceuticals. Based on geography, the demand for radiopharmaceuticals has been the highest in North America due to the presence of excellent research facilities in the region.

Request Report Brochure @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=213

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

Smart Medical Devices Market is Projected to Surpass US$66.1 Bn by 2024

This report provides in-depth analysis of the smart medical devices market. The stakeholders for this report include companies involved in the manufacturing of smart medical devices and its spares parts. For providing a snapshot of this market to the stakeholders, executive summary section is included in this report, which summarizes the market size, trends and competition in different regions. Market share analysis among the market players is analyzed to signify percentage share of the major players operating in the smart medical devices market. Furthermore, the report incorporates market attractiveness analysis by geography that depicts the most attractive and significant region in the global market in 2015.

Obtain Report Details @

https://www.transparencymarketresearch.com/smart-medical-devices-market.html

The research methodology is a combination of primary and secondary research. Primary research includes information collected via e-mails, and telephonic interviews of Key Opinion Leaders (KOL), and forms the bulk of our research. Secondary research includes information collected from various sources, by study of company websites, annual reports, stock analysis presentations, press releases, and various national and international databases.

TMR foresees the global smart medical devices market to post a 7.8% CAGR between 2016 and 2024 to reach a valuation of US$66.1 bn by the final forecast year. The global smart medical devices market was worth a US$38.9 bn in 2017. By 2024, diagnostic and monitoring devices could bag a lion’s share of 47.4% of the global smart medical devices market. Regionally, North America is projected to take the driver’s seat of the global smart medical devices market while posting a 7.5% CAGR.

Request for Sample Copy of Report @

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18344

The global smart medical devices market is forecast to attract high growth opportunities due to the increase in geriatric population susceptible to a wide range of diseases. The growing need for efficiently managing diseases could be a primary factor stoking the demand in the global smart medical devices market. In this regard, it could be said that the healthcare industry can largely benefit from the use of advanced properties of smart medical devices.

Request Report Brochure @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=18344

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

Point-of-care Diagnostics Market is Projected to Surpass US$11.7 bn by 2024

A detailed overview of market dynamics, including the drivers, restraints, and opportunities of the point-of-care diagnostic market, along with porter’s analysis, value chain analysis, of the global market, has been provided in this report. Market revenue and volume analysis for all the above mentioned segments, and their sub segments has been provided for the forecast period of 2016-2024, considering 2015 as the base year, and 2014 as the historical year, along with compound annual growth rate (CAGR %), for the forecast period of 2016-2024. Market share estimations were based on in-depth analysis and study of products, and their features, prices etc. Pricing analysis, for every region has been provided considering the average selling prices (ASP), of products, in these regions.

Obtain Report Details @

https://www.transparencymarketresearch.com/care-diagnostics-market.html

This report provides in-depth analysis of the point-of-care diagnostic market. The stakeholders for this report include companies involved in the manufacturing of Point-of-care Diagnostics. Executive summary section is included snapshot on stakeholders in this report, which summarizes the market size, trends and competition in different regions. Market players and Market share analysis is analyzed to signify percentage share of the major players operating in the point-of-care diagnostic market. Furthermore, the report includes market attractiveness analysis by geography that depicts the most attractive and significant region in the global market in 2015.

Request for Sample Copy of Report @

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1128

The global market for point-of-care diagnostics is predicted to witness a healthy growth in forthcoming years, according a report by Transparency Market Research (TMR). The market ecosystem features high consolidation, with the leading four market players responsible for holding nearly 79% of the entire market share. These leading vendors are, namely, F. Hoffmann-La Roche Ltd., Becton Dickinson and Co., Abbott Inc., and Alere Inc. The prominent players in the global point-of-care diagnostics market are focused offering advanced and improved products. By enhancing their product portfolio, the vendors are expected to sustain the high levels of competition in the worldwide market. Another key strategy that could be adopted by market players is expansion to unexplored and potential regions such as swiftly developing parts of Latin America, Asia Pacific, and Africa.

Request Report Brochure @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1128

TMR’s report estimates that the global point-of-care diagnostics market will rise at a 6.9% CAGR from 2016 to 2024, the period of forecast for the report. In 2016, the market was estimated to be at US$6.8 bn and is predicted to touch US$11.7 bn by the end of 2024.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

Active Pharmaceutical Ingredients (API) Market is Projected to Expand at a CAGR of 5.4% Between 2018 and 2026

Rise in demand for new drugs at a low cost and entry of domestic and global companies in the APIs market have led to innovative product offerings with new and advanced techniques. Any substance or combination of substances used in a finished pharmaceutical product (FPP) is known as active pharmaceutical ingredients (API). A finished dose of any drug is a combination of active pharmaceutical ingredients and excipients. An excipient is an inactive substance in a drug dose.

Obtain Report Details @

https://www.transparencymarketresearch.com/active-pharmaceutical-ingredients.html

High-potency active pharmaceutical ingredients (HPAPIs) and antibody-drug conjugates are recent innovations in the market and require a special manufacturing set up. Most of these drugs are used in oncology. A large number of patents for small molecule APIs are expected to expire in the next few years, with many drugs losing patent protection in 2018. This is estimates to unlock a significant market opportunity for generic drug manufacturers, resulting in augmented demand for APIs. Large pharmaceutical companies are scaling down their small molecule manufacturing facilities to focus on biologic drugs, thereby presenting greater opportunities for contract manufacturing companies, particularly in Asia.

The global active pharmaceutical ingredients market was valued at US$ 162,000.0 Mn in 2017 and is projected to expand at a cumulative annual growth rate (CAGR) of 5.4% from 2018 to 2026, according to a new report published by Transparency Market Research (TMR) titled ‘Global Active Pharmaceutical Ingredients (API)- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2028.’ The report suggests that increase in the use of pharmaceuticals globally is estimated to boost the active pharmaceutical ingredients market between 2018 and 2026. North America and Asia Pacific are projected to dominate the global market, owing an increase in the demand for efficient and effective management of APIs manufacturing, high health care IT budgets, and high adoption of accelerated regulatory review of innovative medicines. The market in Europe is projected to expand at a moderate growth rate of 5.0% during the forecast period. The active pharmaceutical ingredients market in Latin America is likely to expand at a moderate pace during the forecast period. Key factors driving the market in Brazil are rapid improvement in health care infrastructure and increase in purchasing power of the people. In addition, health care companies are striving to cut hospitalization costs while offering better services to patients in the country.

Request for Sample Copy of Report @

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1690

Rise in the prevalence of cancer, cardiovascular diseases, and diabetes; sedentary lifestyles; and a rise in the aging population are key factors driving the active pharmaceutical ingredients (API) market. As per the National Cancer Institute, in 2016, there were an estimated 15.5 million cancer survivors in the U.S.. The number of cancer survivors is expected to increase to 20.3 million by 2026. As per an EU government agency survey, almost 49 million people were living with cardiovascular disease in the EU in 2017. Lung cancer is the leading cause of cancer deaths in Asia Pacific. China alone accounts for more than 50% of all cancer cases in this region. Changes in lifestyle and socio-cultural factors are propelling the incidence of cervical cancer. Major countries affected by breast cancer in Asia Pacific are India, Thailand, and China.

Request Report Brochure @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1690

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

Drug Delivery Systems Market will Register a CAGR of 7.6% through 2025

The global drug delivery systems market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on delivery system, application, route of administration, and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. Moreover, the section encompasses competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global drug delivery systems market.

Obtain Report Details @

https://www.transparencymarketresearch.com/drug-delivery-systems-market.html

Based on delivery systems type the global drug delivery systems market is segmented into intrauterine implants, prodrug implants, polymeric drug delivery, and targeted drug delivery. The type of delivery system segment have been analyzed based on type of devices used to deliver drugs for different applications in various regions. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. According to application the global drug delivery systems market is segmented into infectious diseases, oncology, urology, diabetes, CNS, and others. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Transparency Market Research (TMR) has published a new report titled “Drug Delivery System Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. According to the, the global drug delivery system market was valued at approximately US$ 510.0 Bn in 2016 is projected to expand at CAGR of over 6.9% from 2017 to 2025. The report suggests that rise in prevalence of diseases and increases in demand for self-administration devices are likely to spur demand for drug delivery system in the during the forecast period (2017 to 2025). Key players introduce new drugs delivery systems and devices in developed markets such a North America and Western Europe. Hence, these regions are likely to account for dominant share of the global drug delivery system market. Rise in R&D investment and launch of new and advanced technologies in emerging markets such as Japan and India are expected to boost the drug delivery system market in Asia Pacific. The market in the region is expected to expand at a CAGR of around 7.6% from 2017 to 2025.

Request for Sample Copy of Report @

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=41543

Based on application, the oncology segment is projected to hold a dominant share of the global drug delivery system market during the forecast period. It is likely to expand at CAGR of more than 7.4% from 2017 to 2025. Dominance of this segment is attributed to continuous innovations in drug offerings and wide product portfolio of major and local manufacturers. For instance, in September, 2017, Amgen Inc. and ALLERGAN collectively obtained FDA approval for the use of MVASI to treat five types of cancer, which includes metastatic carcinoma of the cervix, metastatic renal cell carcinoma, glioblastoma, metastatic colorectal cancer (mCRC), and non-squamous non-small cell lung cancer (NSCLC). Continuous launch of new products and increase in the number of patients in developed and developing countries are likely to drive the segment between 2017 and 2025. According to WHO report, in 2015, around 8.8 million people died of cancer, of which, around 1.69 million died of lung cancer and 788,000 succumbed to liver cancer. This highlights the significant need for advanced drug delivery system to treat cancer. CAN and diabetes segment, accounted for more than 36.0% share of global drug delivery system market in 2016, in terms of value. It is anticipated to have substantial growth and account for approximately 36% of market share by 2025.

Request Report Brochure @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=41543

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

Knee Cartilage Repair Market is Projected to Soar at a Value CAGR of 6%from 2018 to 2026

The knee cartilage repair market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on application, end-user, and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. Additionally, the section comprises major players’ product portfolio based on brands, and products in order to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis, by key players, thus presenting a thorough analysis of the overall competitive scenario in the global knee cartilage repair market.

Obtain Report Details @

https://www.transparencymarketresearch.com/knee-cartilage-repair-market.html

Based on application, the market has been segmented into arthroscopic chondroplasty, autologous chondrocyte implantation, osteochondral grafts transplantation, cell-based cartilage resurfacing, implants transplant, microfracture, and others. The application segments have been analyzed based on available approved products, cost-effectiveness, and preference for technologies by physicians and patients. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

The global knee cartilage repair market was valued at approximately US$ 4.0 Bn in 2017. It is projected to expand at a cumulative annual growth rate (CAGR) of 6% from 2018 to 2026, according to a new report published by Transparency Market Research (TMR) titled ‘Knee Cartilage Repair Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ The report suggests that an increase in the number of bone and joint injuries, enhancement in technology, and rise in awareness about health care are expected to propel the knee cartilage repair market in the near future. Additionally, increase in concerns about sports injuries and arthritis-related diseases is anticipated to drive the global market. North America and Europe are projected to dominate the global market, owing to an increase in orthopedic procedures, rise in incidence of obesity, and introduction of technologically advanced products in these regions. The market in Asia Pacific is projected to expand at a prominent CAGR between 2018 and 2026. This is due to increased spending on public health care systems, significant rise in the geriatric population, and increase in adoption of sports activities among the younger generation. The knee cartilage repair market in Latin America is likely to expand at a moderate growth rate during the forecast period.

Request for Sample Copy of Report @

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4481

Arthroscopic chondroplasty involves the repair of a small area of damaged cartilage in the knee. During this procedure, the damaged tissue is removed, allowing healthy cartilage to grow in its place. Meniscal tears are the most common reason for arthroscopic chondroplasty. The damage caused through meniscal tears is trimmed and smoothened down through chondroplasty. Faster recovery time of arthroscopic chondroplasty, as compared to other traditional methods of open knee surgeries, is likely to drive the segment during the forecast period. Technology-based knee cartilage repair are priced on a perpetual license model and are less expensive than other orthopedic surgeries. Arthroscopic chondroplasty enables users to practice low frequency clinical applications, allow healing of extreme pain in musculoskeletal structures, and provide assurance of 90% recovery by physicians. These factors are likely to propel the arthroscopic chondroplasty segment during the forecast period. It is preferred due to its low cost and outpatient procedure, which is used to repair a small area of damaged cartilage in the knee. Furthermore, arthroscopic chondroplasty based on technology facilitates pain relief and increases the range of motion and muscular strength among patients who have a knee injury.

Request Report Brochure @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4481

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

Page 1 of 23

Powered by WordPress & Theme by Anders Norén